Skip to content
10-Q

Quarterly Report

Advanced Biomed Inc ADVB

0001213900-25-112602

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Nov 19, 2025 21.64M sh
Shares Diluted Q1 2026 · Sep 30, 2025 21.64M sh
Shares Diluted Q1 2026 · Sep 30, 2024 20M sh
Capex Q1 2026 · Sep 30, 2025 $1.77K
Capex Q1 2026 · Sep 30, 2024 $19.98K
Operating Cash Flow Q1 2026 · Sep 30, 2025 −$610.34K
Operating Cash Flow Q1 2026 · Sep 30, 2024 −$29.68K
Cash And Equivalents Q1 2026 · Sep 30, 2025 $2.66M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $2.9M
Cash And Equivalents Q1 2026 · Sep 30, 2024 $2.65M
Cash And Equivalents Q1 2026 · Jun 30, 2024 $2.61M
Stockholders Equity Q1 2026 · Sep 30, 2025 $3M
Stockholders Equity Q1 2026 · Jun 30, 2025 $3.48M
Stockholders Equity Q1 2026 · Sep 30, 2024 $1.09M
Stockholders Equity Q1 2026 · Jun 30, 2024 $1.66M
Current Liabilities Q1 2026 · Sep 30, 2025 $3.04M
Current Liabilities Q1 2026 · Jun 30, 2025 $2.89M
Total Liabilities Q1 2026 · Sep 30, 2025 $3.24M
Total Liabilities Q1 2026 · Jun 30, 2025 $3.03M
Current Assets Q1 2026 · Sep 30, 2025 $5.84M
Current Assets Q1 2026 · Jun 30, 2025 $6.03M
Total Assets Q1 2026 · Sep 30, 2025 $6.24M
Total Assets Q1 2026 · Jun 30, 2025 $6.51M
Eps Diluted Q1 2026 · Sep 30, 2025 −$0.02
Eps Diluted Q1 2026 · Sep 30, 2024 −$0.01
Eps Basic Q1 2026 · Sep 30, 2025 −$0.02
Eps Basic Q1 2026 · Sep 30, 2024 −$0.01
Sga Expense Q1 2026 · Sep 30, 2025 $287.92K
Sga Expense Q1 2026 · Sep 30, 2024 $338.32K
Rd Expense Q1 2026 · Sep 30, 2025 $235.99K
Rd Expense Q1 2026 · Sep 30, 2024 $181.7K
Net Income Q1 2026 · Sep 30, 2025 −$386.9K
Net Income Q1 2026 · Sep 30, 2024 −$265.58K